114 Pill - white round, 8mm
Pill with imprint 114 is White, Round and has been identified as Oxycodone Hydrochloride 30 mg. It is supplied by Mylan Pharmaceuticals Inc.
Oxycodone is used in the treatment of Chronic Pain; Back Pain; Pain and belongs to the drug class Opioids (narcotic analgesics). FDA has not classified the drug for risk during pregnancy. Oxycodone 30 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for 114
Oxycodone Hydrochloride
- Imprint
- 114
- Strength
- 30 mg
- Color
- White
- Size
- 8.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Opioids (narcotic analgesics)
- Pregnancy Category
- N - Not classified
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- Inactive Ingredients
-
microcrystalline cellulose,
lactose monohydrate,
corn starch,
silicon dioxide,
stearic acid
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00378-6114 (Discontinued) | Mylan Pharmaceuticals Inc. |
| 68308-0112 (Discontinued) | Midlothian Laboratories LLC |
Related images for "114"
More about oxycodone
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,152)
- Drug images
- Latest FDA alerts (3)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: Opioids (narcotic analgesics)
- Breastfeeding
- En español
Patient resources
- Oxycodone drug information
- Oxycodone Capsules and Tablets
- Oxycodone Extended-Release Capsules
- Oxycodone Concentrate
- Oxycodone Solution
- Oxycodone Sustained-Release Tablets
Other brands
OxyContin, Roxicodone, Xtampza ER, Oxaydo, ... +8 more
Professional resources
- Oxycodone monograph
- Oxycodone (FDA)
- Oxycodone Capsules (FDA)
- Oxycodone ER (FDA)
- Oxycodone Extended-Release Tablets (FDA)
Other brands
OxyContin, Roxicodone, Xtampza ER, Oxaydo, RoxyBond
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
